Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 200815-49-2
2. Brovana
3. (r,r)-arformoterol Tartrate
4. Arformoterol Tartrate [usan]
5. 5p8vj2i235
6. Arformoterol Tartrate (usan)
7. Formamide, N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, (2r,3r)-2,3-dihydroxybutanedioate (1:1)
8. (r,r)-formoterol Tartrate
9. (-)-n-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide Hydrogen (2r,3r)-2,3-dihydroxybutanedioate (salt)
10. Formamide, N-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-, (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)
11. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-formamide (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)
12. Brovana Inhalation Solution
13. Unii-5p8vj2i235
14. Brovana (tn)
15. Arformotero Ltartrate
16. Dtxsid80173903
17. Arformoterol Tartrate [vandf]
18. S5217
19. Arformoterol Tartrate [mart.]
20. Akos005145740
21. Arformoterol Tartrate [who-dd]
22. Ccg-269651
23. Arformoterol Tartrate, >=98% (hplc)
24. Ba171831
25. Bs-42158
26. Arformoterol Tartrate [orange Book]
27. Formoterol R,r-form L-tartrate [mi]
28. D02981
29. 815f492
30. Q-101035
31. Q27262686
32. (2r,3r)-2,3-dihydroxybutanedioic Acid;n-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide
33. (r,r)-formoterol Tartrate; N-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide (2r,3r)-2,3-dihydroxybutanedioate (1:1)
34. [(2r)-2-(3-formamido-4-hydroxyphenyl)-2-hydroxyethyl]-[(2r)-1-(4-methoxyphenyl)propan-2-yl]azanium;(2r,3r)-2,3,4-trihydroxy-4-oxobutanoate
35. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide (2r,3r)-2,3-dihydroxybutane Dioate
36. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide (2r,3r)-2,3-dihydroxybutanedioate
37. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide L-tartrate
Molecular Weight | 494.5 g/mol |
---|---|
Molecular Formula | C23H30N2O10 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 11 |
Exact Mass | 494.19004516 g/mol |
Monoisotopic Mass | 494.19004516 g/mol |
Topological Polar Surface Area | 206 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 521 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Brovana |
PubMed Health | Arformoterol (By breathing) |
Drug Classes | Bronchodilator |
Active Ingredient | Arformoterol tartrate |
Dosage Form | Solution |
Route | Inhalation |
Strength | eq 0.015mg base/2ml |
Market Status | Prescription |
Company | Sunovion |
2 of 2 | |
---|---|
Drug Name | Brovana |
PubMed Health | Arformoterol (By breathing) |
Drug Classes | Bronchodilator |
Active Ingredient | Arformoterol tartrate |
Dosage Form | Solution |
Route | Inhalation |
Strength | eq 0.015mg base/2ml |
Market Status | Prescription |
Company | Sunovion |
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
100
PharmaCompass offers a list of Arformoterol Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Arformoterol Tartrate manufacturer or Arformoterol Tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Arformoterol Tartrate manufacturer or Arformoterol Tartrate supplier.
PharmaCompass also assists you with knowing the Arformoterol Tartrate API Price utilized in the formulation of products. Arformoterol Tartrate API Price is not always fixed or binding as the Arformoterol Tartrate Price is obtained through a variety of data sources. The Arformoterol Tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Brovana manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Brovana, including repackagers and relabelers. The FDA regulates Brovana manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Brovana API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Brovana manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Brovana supplier is an individual or a company that provides Brovana active pharmaceutical ingredient (API) or Brovana finished formulations upon request. The Brovana suppliers may include Brovana API manufacturers, exporters, distributors and traders.
click here to find a list of Brovana suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Brovana DMF (Drug Master File) is a document detailing the whole manufacturing process of Brovana active pharmaceutical ingredient (API) in detail. Different forms of Brovana DMFs exist exist since differing nations have different regulations, such as Brovana USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Brovana DMF submitted to regulatory agencies in the US is known as a USDMF. Brovana USDMF includes data on Brovana's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Brovana USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Brovana suppliers with USDMF on PharmaCompass.
A Brovana written confirmation (Brovana WC) is an official document issued by a regulatory agency to a Brovana manufacturer, verifying that the manufacturing facility of a Brovana active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Brovana APIs or Brovana finished pharmaceutical products to another nation, regulatory agencies frequently require a Brovana WC (written confirmation) as part of the regulatory process.
click here to find a list of Brovana suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Brovana as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Brovana API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Brovana as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Brovana and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Brovana NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Brovana suppliers with NDC on PharmaCompass.
Brovana Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Brovana GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Brovana GMP manufacturer or Brovana GMP API supplier for your needs.
A Brovana CoA (Certificate of Analysis) is a formal document that attests to Brovana's compliance with Brovana specifications and serves as a tool for batch-level quality control.
Brovana CoA mostly includes findings from lab analyses of a specific batch. For each Brovana CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Brovana may be tested according to a variety of international standards, such as European Pharmacopoeia (Brovana EP), Brovana JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Brovana USP).